Our culture of integrity, accountability, and transparency
Since the beginning of 2025, Fresenius Kabi has been an associate member of the Pharmaceutical Supply Chain Initiative (PSCI). This initiative by leading pharmaceutical and healthcare companies promotes responsible supply chain practices and ethical sourcing standards. The PSCI's core principles provide clear guidance for suppliers on ethics, labor rights, health and safety, environmental sustainability, and management systems.
We act in line with the Fresenius Principles, which include complying with all relevant laws and regulations. We proactively identify and manage potential risks to our company, our operations, and, most importantly, our employees and patients.
We thoroughly analyze and address these risks using our Compliance Management System, based on three pillars:
Our compliance tools include:
We identify potential cases of misconduct via:
We manage reported incidents through:
Whether you are an employee, customer, supplier, or third party, you can report potential compliance violations or human rights risks linked to our operations.
To ask questions, seek guidance, or report any suspected misconduct, you can:
You can make your report anonymously and in your preferred language. Translation services are also available.
All submissions are treated carefully and confidentially by an independent team of experienced compliance investigators. They report directly to our Chief Compliance Officer.
To ensure we protect all people who speak up, we do not tolerate any forms of retaliation. You can find detailed information on our case management process and other reporting channels in our Speak Up Policy.
We are committed to complying with applicable anti-corruption and anti-bribery (ABC) laws. Our comprehensive global ABC Policy outlines clear rules and principles to avoid bribery and corruption, both within our company and by third parties.
Without exception, our employees must comply with antitrust laws in all locations and in all third-party interactions and transactions. Our global Antitrust Policy includes risk assessments, controls for sensitive transactions, training and communication, reporting of antitrust cases, and remediation, monitoring, and legal support. With this comprehensive policy, we help to ensure antitrust compliance across all our business operations and legal entities.
Our human rights program aims to uphold human rights across our operations and global supply chains. We have implemented a robust due diligence process to identify, prevent, and address potential human rights impacts. We also expect our suppliers and business partners to mirror these rules and standards, defined in our Third-Party Code of Conduct.
Comprehensive information on the Fresenius human rights program can be found on our Fresenius Group human rights pages.
Respecting human rights is integral to our principles, mission, and operations. We strive to make positive contributions to society and uphold the dignity of everyone involved in our business.
Within our approach is a desire to continuously learn and improve. We enhance our human rights practices through ongoing training, awareness campaigns, and fostering a culture of integrity and accountability.
Fresenius Kabi is a fully consolidated subsidiary of Fresenius SE. This website includes an overview of the Fresenius Kabi sustainability commitment. All data on this website corresponds to a subset of group data that is published in the Fresenius Group Sustainability Statement 2024 and thus is assured by an external auditor. The Sustainability Statement is prepared in full compliance with the European Sustainability Reporting Standards (ESRS).
